迈瑞医疗收盘上涨1.02%，滚动市盈率25.75倍，总市值2868.15亿元

Group 1 - The core viewpoint of the articles highlights that Mindray Medical's stock closed at 236.56 yuan, with a rolling PE ratio of 25.75 times and a total market capitalization of 286.815 billion yuan [1] - The average PE ratio for the medical device industry is 59.32 times, with a median of 39.97 times, positioning Mindray Medical at the 50th rank within the industry [1] - As of March 31, 2025, the number of shareholders for Mindray Medical increased to 92,191, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Mindray Medical's main business includes the research, manufacturing, marketing, and service of medical devices, with key products in life information and support, in vitro diagnostics, medical imaging, electrophysiology, and vascular intervention [1] - The latest quarterly report for Q1 2025 shows that the company achieved operating revenue of 8.237 billion yuan, a year-on-year decrease of 12.12%, and a net profit of 2.629 billion yuan, down 16.81% year-on-year, with a gross profit margin of 62.53% [1] - The PE ratios of other companies in the medical device industry range from 11.61 times for Ji'an Medical to 20.96 times for Antu Bio, with Mindray Medical's PE ratio being significantly lower than the industry average [2]